Track topics on Twitter Track topics that are important to you
Glaukos reported a net income of $0.9 million, or $0.02 per diluted share, in the first quarter of 2017 compared with $0.9 million, or $0.03 per diluted share, in the same quarter of 2016. Net sales were $35.9 million, a 55% increase compared with $23.1 million in the first quarter a year ago, according to a company press release.
Original Article: Glaukos posts $0.9 million in first-quarter incomeNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...